Regarding the FDA notice about Librela
We want to share an important update about Librela (bedinvetmab), a medication used to help dogs manage osteoarthritis pain. The FDA has noted some additional potential side effects, but they’ve determined that Librela is still safe to use and remains available. That said, we understand this may raise concerns. If you’ve noticed any side effects in your dog or would like to pause treatment, please don’t hesitate to reach out. We’re here to listen, answer any questions, and report any issues to the manufacturer. If you’d like to cancel an upcoming appointment for Librela, just let us know–we’re happy to help. Your pet’s well-being is always our top priority. You can see the FDA notice about Librela here. [link]
Some of the additional side effects listed by the FDA can be normal for older dogs. However, if your dog is receiving Librela injections, and you notice any of the following side effects, please contact us for further guidance.
- Unsteady walking (ataxia) – difficulty maintaining balance or coordination
- Clumsiness or loss of awareness of paw placement – dragging paws or not knowing where their feet are placed
- Lying down and unable to get up – difficulty rising or inability to rise
- Increased muscle weakness – trouble standing or reduced strength
- Difficulty moving limbs – partial loss of movement or control in legs
- Limping – noticeable lameness or avoiding putting weight on a limb
- Paralysis – inability to move part or all of the body
- Shaking or trembling – involuntary muscle movements or tremors
- Seizures – episodes of convulsions or shaking that may involve loss of consciousness
- Fainting or sudden collapse – sudden loss of strength or consciousness
- Autoimmune reactions – signs like fever, swollen joints, or unusual symptoms that may indicate an overactive immune system
- Severe illness or death – while rare, this is a serious outcome to be aware of
